2022 Annual Golden Arrow Awards for Insurance Companies
The Institute of Corporate Directors, in partnership with the Insurance Commission, will be holding the 2022 Annual Golden Arrow Awards for Insurance Companies.
The GOLDEN ARROW is awarded to Insurance Commission Regulated Companies (ICRCs) that achieved a score of at least 80 points in the 2021 Corporate Governance Scorecard (CGS) Assessment. Five (5) levels of performance in corporate governance will be bestowed. Each ascending level is depicted by an increasing number of golden arrows, as follows:
ACGS score of 80 to 89 points 1-arrow recognition ACGS score of 90 to 99 points 2-arrow recognition ACGS score of 100 to 109 points 3-arrow recognition ACGS score of 110 to 119 points 4-arrow recognition ACGS score of 120 to 130 points 5-arrow recognition The golden upward-pointing arrow symbolizes the continuing efforts of the Philippine companies to raise the level of compliance with the ASEAN corporate governance principles. This is a hybrid event. The awardees are invited to send at most two (2) representatives onsite. The ceremony will also be live-streamed via Zoom. To attend online, kindly send to cga@icd.ph your representatives' names and email addresses for the login credentials. PROGRAM
When: 23 September 2022 (Friday), 2:00-4:00 pm Where: IIAP Main Function Hall, 26th floor of BPI-Philam Life Makati, 6811 Ayala Avenue, Salcedo Village, Bel-Air, Makati City (Live-streamed via Zoom) 2:00 - 2:05 Invocation & National Anthem 2:05 - 2:15 Message from the Insurance Commission Atty. Dennis B. Funa, FICD Insurance Commissioner 2:15 - 2:25 Message from the Institute of Corporate Directors Atty. Cesar L. Villanueva, FICD Chairman 2:25 - 2:40 Presentation of the 2021 CGS Results Ms. Rebecca G. Sarmenta, FICD Chair, CG Standards Committee 2:40 - 3:10 Recognition of Awardees 3:10 - 3:15 ICD & IC Commercial 3:15 - 3:45 Message from the 3-Golden Arrow Awardees 3:45 - 3:50 Message from the Most Improved Company 3:50 - 4:00 Closing Remarks Mr. Carlos Jose P. Gatmaitan, PhD, FICD Chief Executive Officer, ICD
Comments